EPO Patents = 2

Forward Citations = 0

Loading Chart...

18 inventors (with patents filed for the assignee):

Takashi Nakai (2 out of 23 patents)

Ara Mermerian (2 out of 18 patents)

Glen Robert Rennie (2 out of 32 patents)

4. Paul A Renhowe (2 out of 59 patents)

5. Thomas Storz (2 out of 4 patents)

6. G-Yoon Jamie Im (1 out of 13 patents)

7. Rajesh R Iyengar (1 out of 26 patents)

8. Thomas Wai-Ho Lee (1 out of 17 patents)

9. Lei Jia (1 out of 15 patents)

10. Karthik Iyer (1 out of 10 patents)

11. Joon Jung (1 out of 23 patents)

12. Peter Germano (1 out of 4 patents)

13. Kim Tang (1 out of 5 patents)

14. Kwame Wiredu Nti-Addae (1 out of 9 patents)

15. Leena Kumari Prasad (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12435080 - sGC stimulators (2025-10-07),

2. 12220414 - Use of sGC stimulators for the treatment of mitochondrial disorders (2025-02-11),

3. 12122782 - Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators (2024-10-22),

4. 12054489 - Substituted amidrazones as intermediates in the process for preparing soluble guanylate cyclase stimulators (2024-08-06),

5. 11897887 - sGC stimulators (2024-02-13),

Tisento Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for autoimmune diseases and other serious conditions. The company leverages advanced technologies to create targeted treatments that aim to improve patient outcomes. With a commitment to scientific excellence and patient-centric approaches, Tisento is dedicated to addressing unmet medical needs through its research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#335 in Cambridge, MA

#2,814 in Massachusetts

#50,234 in US

Cambridge, MA, United States of America

Tisento Therapeutics Inc.